Evidence map›Paper›PMID 28680351›Full record

ArticleJournal of medical biochemistry2017

Endothelial Dysfunction Markers in Low Cardiovascular Risk Individuals: Comparison of Males and Females.

Zeynep B Gungor, Nurver Sipahioglu, Huseyin Sonmez, Hakan Ekmekci, Sait Toprak, Gulsel Ayaz, Cigdem Bayram Gurel, Tugba Mutlu, Turgut Ulutin, Fikret Sipahioglu and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of medical biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Zeynep B GungorDepartment of BiochemistryIstanbul, Turkey.
Nurver SipahiogluDepartment of Family MedicineIstanbul, Turkey.
Huseyin SonmezDepartment of BiochemistryIstanbul, Turkey.
Hakan EkmekciDepartment of BiochemistryIstanbul, Turkey.
Sait ToprakDepartment of BiochemistryIstanbul, Turkey.
Gulsel AyazDepartment of Medical BiologyIstanbul, Turkey.
Cigdem Bayram GurelDepartment of Medical BiologyIstanbul, Turkey.
Tugba MutluDepartment of Medical BiologyIstanbul, Turkey.
Turgut UlutinDepartment of Medical BiologyIstanbul, Turkey.
Fikret SipahiogluDepartment of Internal MedicineIstanbul, Turkey.
Baris IlerigelenDepartment of Cardiology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey.
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular diseases (CVD) account for approximately 50% of the total deaths in Turkey. Most of them are related with atherosclerotic coronary heart disease. Predictive value of endothelial dysfunction markers related with the earliest stage of atherosclerosis has been getting more attention. We hypothesized that differences in endothelial dysfunction biochemical markers among genders would aid to capture proatherogenic activity that was not diagnosed by conventional risk assessment scoring systems.

methodsWe assessed the endothelial dysfuntion markers in 92 Turkish adults who were in the »low CV risk group« according to ESC (European Society of Cardiology)-Score Risk Charts. We compared the males and females.

resultsWe observed higher endothelial dysfunction rates in males, with higher median and mean levels of e-NOS, ox-LDL before and after adjustment for HDL lowness and obesity (P=0.018, P=0.036 for NOS; P=0.000, P=0.004 for ox-LDL, respectively). Men had higher hs-CRP levels than females before adjustment (P=0.021). Decreased e-NOS levels were related with FMD for females before adjustment for confounders (P=0.028). We also found significant correlation between e-NOS and ox-LDL levels both before (r=0.360, P<0.001) and after adjustment (r=0.366, P<0.01) for confounders which pointed out the nitrosative stress. In multivariate regression analyses, after adjusting for other endothelial dysfunction markers which were not included in the ESC-risk scoring system, decreased e-NOS levels were independently asssociated with impaired flow mediated dilatation for females (odds ratio 0.3; P=0.038).

conclusionsOur results underline the importance of gender in evaluating endothelial dysfunction biochemical markers to assess cardiovascular risk for low CV risk indivuals.

Indexed as

endothelial dysfunctionflow mediated dilatation (FMD)genderlow cardiovascular (CV) riskoxidized LDL (ox-LDL)

Identifiers

PMID28680351
PMCPMC5471661
OpenAlexW2581084410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.